Advertisement

Topics

Onxeo sells legacy products to focus on orphan oncology drugs

07:09 EDT 1 Aug 2017 | thePharmaLetter

Paris-headquartered Onxeo has divested two legacy products, Sitavig and Loramyc, to another French firm,…

Original Article: Onxeo sells legacy products to focus on orphan oncology drugs

NEXT ARTICLE

More From BioPortfolio on "Onxeo sells legacy products to focus on orphan oncology drugs"

Quick Search
Advertisement